| |
Departments
of Pediatrics (MLG), Pathology (DRJ, JSP), Dermatology (MSK, JSP), and Immunobiology
(JSP), Yale University School of Medicine, New Haven, Connecticut
|
| |
SUMMARY: TNF signals are mediated through two different receptors,
TNFR1 and TNFR2. In endothelial cells, TNFR1 is predominantly localized
in the Golgi apparatus and TNFR2 on the plasma membrane. To investigate
structural features responsible for the disparate localization, endothelial
cells were transfected with epitope-tagged or green fluorescent protein-fused
wild type and mutant receptor molecules. Wild type receptors recapitulated
the distribution of endogenous receptors. Deletions of the entire TNFR1
intracellular domain or of the C-terminal death domain (TNFR1-DD)
allowed expression of the receptor on the plasma membrane. However, addition
of the death domain to the C-terminus of TNFR2 (TNFR2+DD) did
not lead to Golgi-retention of this chimeric receptor. Overexpressed TNFR1,
TNFR2, and TNFR2 +DD increased basal expression of a cotransfected
NF-KB-dependent promotor-reporter gene. Overexpressed
TNFR1-DD did not activate NF-KB but
acted as a ligand-specific dominant negative inhibitor of TNF actions.
Unexpectedly, TNF responses were also inhibited by overexpressed TNFR1
and TNFR2+DD, but not TNFR2. We conclude that the death domain
of TNFR1 is required for retention of TNFR1 in the Golgi apparatus but
is not sufficient to direct Golgi retention of a TNFR2+DD chimera,
and that overexpressed receptors that contain the death domain (TNFR1
and TNFR2+DD) spontaneously activate NF-KB
while inhibiting TNF responses.
|